• Hear what our customers have to say about us…

 

  • Tero Sat, Project Director (Glykos): “OcellO has a unique and powerful screening platform, which greatly helped us to demonstrate efficacy of one of Glykos’ ADC’s in development. Using advanced imaging techniques on patient-derived xenografts grown in 3D culture, OcellO was able to deliver relevant and solid data fast and were highly oriented towards addressing our specific needs. “

     

  • Wim Dokter, Vice President Preclinical (Synthon Biopharmaceuticals): “At Synthon, we were very satisfied with the services provided by OcellO as a reliable contract research partner. Their innovative platform combining imaging technology and 3D cell culture yielded insightful results that could not have been easily obtained otherwise. The interpretation of generated data was honest, fair and our high-quality discussions were very constructive.”

     

  • Mark Throsby, CSO (Merus): “OcellO has a unique, high throughput and multi-dimensional screening platform which Merus has successfully utilized to functionally characterize thousands of bispecific antibodies directed against various target combinations. The depth of information that OcellO generates on the effects of our therapeutics on cultured tumour tissues plays an important role in our lead selection process and was crucial in the development of our lead program now in phase I/II clinical trials. ”